On-demand Webcast

Share

Program Content

Activities

  • Precision Therapeutics in NF1 Associated Tumors
    Precision Therapeutics for NF1-Associated Tumors: Improved Outcomes Through Targeted MEK Inhibition
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 24, 2024

    Expires: June 23, 2025

Faculty

cover img faculity

Jaishri Blakeley, MD

The Marjorie Bloomberg Tiven Professor of Neurofibromatosis
Director, The Neurofibromatosis Therapeutic Acceleration Program
Director, the Johns Hopkins Comprehensive Neurofibromatosis Program
Professor of Neurology, Neurosurgery and Oncology
The Johns Hopkins School of Medicine
Baltimore, Maryland

cover img faculity

Miriam Bornhorst, MD

Neuro-Oncologist
Max Lacewell Endowed Brain Tumor Research Scholar
NF-Oncology
Ann & Robert H. Lurie Children’s Hospital
Stanley Manne Children’s Research Institute
Associate Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, Illinois

cover img faculity

Michael J. Fisher, MD

Chief, Neuro-Oncology Section
Director, Neurofibromatosis Program
Hubert J.P. and Anne Faulkner Schoemaker Endowed Chair in Pediatric Neuro-Oncology
Center for Childhood Cancer Research and Division of Oncology
The Children’s Hospital of Philadelphia
Professor of Pediatrics
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania

Provided by

ProCE Banner

Supporters

Supported by educational grants from Alexion Pharmaceuticals and SpringWorks Therapeutics, Inc.

Alexion Pharmaceuticals

SpringWorks Therapeutics, Inc.